At the American College of Rheumatology (ACR) meeting, SRF-funded investigator Dr. Kathryn Torok presented on the use of Autologous Stem Cell Transplantation (ASCT) for Treatment-Resistant Juvenile-Onset Systemic Sclerosis. The results of this small case series of three patients support the use of ASCT with CD34-Selected Peripheral Blood Stem Cells as a treatment for juvenile-onset systemic sclerosis in patients who have failed other standard therapies. One of the patients involved in the study describes the date of his transplant as his “re-birthday” and says that his “energy and mobility are at an all-time high”.
Held this week, the ACR Meeting is a prestigious gathering where clinicians, researchers, and biopharmaceutical representatives from all over the world meet to present the latest progress in rheumatic disease research and clinical trials.
